Three high quality companies that can generate real value
Professional investor Christopher Rossbach of J. Stern & Co picks three high-quality companies trading at very attractive prices.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
I’ve just come back from the Berkshire Hathaway annual meeting in Omaha where Warren Buffett and Charlie Munger spoke about their latest investments. Munger famously once said that “micro is what we do, macro is what we put up with”. In other words, investment decisions should be formed by focusing on what companies are doing and what opportunities they are seeing, rather than being swayed by macroeconomic conditions.
This underpins our approach at J. Stern & Co. We look to invest in quality companies that can generate real value over the long term. This year’s stockmarket correction means many quality companies are trading at very attractive prices.
We believe that if a company can show it has the pricing power to offset inflation as well as the innovation required to grow, then it will be well-positioned for what comes next. Any weakness is as much an opportunity for us as it is for Berkshire Hathaway, or indeed any long-term investor.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Chips for future tech
Nvidia (Nasdaq: NVDA) is the leading manufacturer of high-end graphics processing units (GPUs). It’s currently trading around 40% lower than it was at the start of the year, and we capitalised on this dip to add it to our World Stars Global Equity Fund.
The company’s semiconductor chips power the high-performance computing infrastructure within data centres and are aiding the development and growing adoption of modern artificial intelligence.
Alongside its core business of gaming graphics hardware, it also has very attractive long-term opportunities in self-driving vehicles as well as augmented and virtual reality, namely the metaverse.
Enabling electrification
Amphenol (NYSE: APH) is a global leader in connectors and sensors. It embraces the type of innovation that we believe will see the company dominate over the next decade as the world adopts the “electrification of everything”. This includes more connected cars (those that communicate with systems outside the car) as well as electric vehicles, the shift to renewable power generation, the emergence of smart factories and nextgeneration communications technology.
The company has a proven record of shielding profitability by managing its costs, and it also benefits from customers leaning on larger, more established suppliers with diverse manufacturing footprints. This trend has been reinforced by the significant bottlenecks in global supply chains due to the pandemic and accentuated by the Ukraine crisis.
Looking for innovative solutions
Alcon (Zurich: ALC), the global leader in eye care that spun out of pharmaceutical company Novartis in 2019, is currently trading below its historical average valuation. Contact-lens wearers may be familiar with its products, but it also makes implantable lenses for surgical equipment for cataract surgeries.
Over the past three years the company has invested in innovation and has since launched several new products, including Vivity, a one-of-a-kind intraocular lens for cataracts that reduces glare and halo where competitors’ lenses cannot. Its first-quarter results for 2022 were testimony to this investment: both revenues and profits exceeded expectations and management raised its 2022 full-year outlook despite the uncertain macro environment, inflation, and war in Ukraine
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Chris is a Managing Partner and Chief Investment Officer of tJ. Stern & Co. Chris is also the portfolio manager of the Firm’s World Stars investment strategy.
-
How a ‘great view’ from your home can boost its value by 35%A house that comes with a picturesque backdrop could add tens of thousands of pounds to its asking price – but how does each region compare?
-
What is a care fees annuity and how much does it cost?How we will be cared for in our later years – and how much we are willing to pay for it – are conversations best had as early as possible. One option to cover the cost is a care fees annuity. We look at the pros and cons.
-
Three key winners from the AI boom and beyondJames Harries of the Trojan Global Income Fund picks three promising stocks that transcend the hype of the AI boom
-
RTX Corporation is a strong player in a growth marketRTX Corporation’s order backlog means investors can look forward to years of rising profits
-
Profit from MSCI – the backbone of financeAs an index provider, MSCI is a key part of the global financial system. Its shares look cheap
-
'AI is the real deal – it will change our world in more ways than we can imagine'Interview Rob Arnott of Research Affiliates talks to Andrew Van Sickle about the AI bubble, the impact of tariffs on inflation and the outlook for gold and China
-
Should investors join the rush for venture-capital trusts?Opinion Investors hoping to buy into venture-capital trusts before the end of the tax year may need to move quickly, says David Prosser
-
Food and drinks giants seek an image makeover – here's what they're doingThe global food and drink industry is having to change pace to retain its famous appeal for defensive investors. Who will be the winners?
-
Barings Emerging Europe trust bounces back from Russia woesBarings Emerging Europe trust has added the Middle East and Africa to its mandate, delivering a strong recovery, says Max King
-
How a dovish Federal Reserve could affect youTrump’s pick for the US Federal Reserve is not so much of a yes-man as his rival, but interest rates will still come down quickly, says Cris Sholto Heaton